CSF2 and pachyonychia congenita: Interestingly, PD-1/PD-L1 inhibitors significantly enhanced the efficacy of SA-GM-CSF surface-modified tumor vaccines against PC, which may be a new application for PD-1/PD-L1 inhibitors in the treatment of PC (127).